Lilly’s Pill Foundayo Gets EU Nod for Obesity and Diabetes
What happened
- Summary: Bloomberg headline reports that Lilly's pill Foundayo received EU approval for obesity and diabetes.
- Key point: Bloomberg reports an EU nod for Lilly's pill Foundayo for obesity and diabetes.
- Qualification: Evidence is headline-only; no article body details are supplied.
Original reporting
- Lilly’s Pill Foundayo Gets EU Nod for Obesity and Diabetes ↗
Bloomberg · Published Oct 16, 2026